Metasphere Labs Inc.
LABZ
CNSX
01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
---|---|---|---|---|---|
Net Income | -130.74% | 91.63% | 99.97% | 97.73% | 97.79% |
Total Depreciation and Amortization | -28.68% | -86.56% | -84.01% | -91.41% | -95.05% |
Total Amortization of Deferred Charges | -55.04% | -55.04% | -55.04% | 103.81% | 68.08% |
Total Other Non-Cash Items | -39.14% | -92.06% | -91.89% | -90.10% | -93.46% |
Change in Net Operating Assets | -9.12% | -844.23% | -538.83% | -413.18% | -197.93% |
Cash from Operations | -356.21% | -54.85% | 46.96% | 72.84% | 93.33% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -100.00% | -100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | 103.86% | 101.58% |
Cash from Investing | -- | -- | -- | 213.91% | 101.96% |
Total Debt Issued | -- | -101.75% | -100.00% | -108.56% | -108.28% |
Total Debt Repaid | -357.96% | -412.63% | -595.49% | 97.43% | 142.51% |
Issuance of Common Stock | 47.93% | 533.53% | 484.39% | 205.25% | 136.80% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 27.12% | 84.07% | 22.60% | -32.45% | -31.12% |
Foreign Exchange rate Adjustments | -- | -- | -- | 100.00% | 100.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -163.85% | 648.67% | 1,823.08% | 119.64% | 111.03% |